A Study of LY3415244 in Participants With Advanced Solid Tumors
Clinical trial NCT03752177 · TERMINATED
Trial details
- NCT number
- NCT03752177
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-22
- Primary completion
- 2019-10-09
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.